Relapse Prevention via Videoconference for Anorexia Nervosa - Findings from the RESTART Pilot Study
Authors: Katrin E. Giel, Elisabeth J. Leehr, Sandra Becker, Wolfgang Herzog, Florian Junne, Ulrike Schmidt, Stephan Zipfel
Journal: Psychotherapy and Psychosomatics (2015)

Letters| September 25 2015 Relapse Prevention via Videoconference for Anorexia Nervosa - Findings from the RESTART Pilot Study Subject Area: Psychiatry and Psychology Katrin E. Giel; Katrin E. Giel Department of Psychosomatic Medicine and Psychotherapy, Medical University Hospital Tübingen, Tübingen, and Department of General Internal Medicine and Psychosomatics, University Hospital Heidelberg, Heidelberg, Germany; Katrin.Giel@med.uni-tuebingen.de Search for other works by this author on: This Site PubMed Google Scholar Elisabeth J. Leehr; Elisabeth J. Leehr Department of Psychosomatic Medicine and Psychotherapy, Medical University Hospital Tübingen, Tübingen, and Search for other works by this author on: This Site PubMed Google Scholar Sandra Becker; Sandra Becker Department of Psychosomatic Medicine and Psychotherapy, Medical University Hospital Tübingen, Tübingen, and Search for other works by this author on: This Site PubMed Google Scholar Wolfgang Herzog; Wolfgang Herzog Department of General Internal Medicine and Psychosomatics, University Hospital Heidelberg, Heidelberg, Germany; Search for other works by this author on: This Site PubMed Google Scholar Florian Junne; Florian Junne Department of Psychosomatic Medicine and Psychotherapy, Medical University Hospital Tübingen, Tübingen, and Search for other works by this author on: This Site PubMed Google Scholar Ulrike Schmidt; Ulrike Schmidt Section of Eating Disorders, Psychological Medicine, Institute of Psychiatry, King's College London, London, UK Search for other works by this author on: This Site PubMed Google Scholar Stephan Zipfel Stephan Zipfel Department of Psychosomatic Medicine and Psychotherapy, Medical University Hospital Tübingen, Tübingen, and Search for other works by this author on: This Site PubMed Google Scholar Katrin.Giel@med.uni-tuebingen.de Psychother Psychosom (2015) 84 (6): 381–383. https://doi.org/10.1159/000431044 Article history Received: January 21 2015 Accepted: April 28 2015 Published Online: September 25 2015 Content Tools Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn MailTo Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation Katrin E. Giel, Elisabeth J. Leehr, Sandra Becker, Wolfgang Herzog, Florian Junne, Ulrike Schmidt, Stephan Zipfel; Relapse Prevention via Videoconference for Anorexia Nervosa - Findings from the RESTART Pilot Study. Psychother Psychosom 1 October 2015; 84 (6): 381–383. https://doi.org/10.1159/000431044 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsPsychotherapy and Psychosomatics Search Advanced Search This content is only available via PDF. © 2012 S. Karger AG, Basel2015Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Article PDF first page preview Close Modal You do not currently have access to this content.